Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 101 entries
Sorted by: Best Match Show Resources per page
From FBA to implementation: A look at what is actually being delivered

out of school settings

Blood E.
GSID: FJMzJ32jzYUJ
E Blood, RS Neel - Education and Treatment of Children, 2007 - JSTOR

This study looks at the utilization of assessments on developing behavior intervention plans (BIPs) and their use in designing actual implementation for the children (elementary through …

Cite
Blood, E., & Neel, R. S. (2007). From FBA to implementation: A look at what is actually being delivered. Education and Treatment of Children, 67-80.
Blood, Erika, and Richard S. Neel. "From FBA to implementation: A look at what is actually being delivered." Education and Treatment of Children (2007): 67-80.
Copy Download .nbib Format: MLA
Embedding “Clickers” into classroom instruction: Benefits and strategies

classroom instruction

Blood E.
GSID: ajecWkD8CYcJ
E Blood, D Gulchak - Intervention in School and Clinic, 2013 - journals.sagepub.com

… Student response systems, often called clickers, have become more popular and visible in the K–12 classroom in recent years. There are … Both students and teachers see student response systems as a positive addition to the classroom environment....

Cite
Blood, E., & Gulchak, D. (2013). Embedding “Clickers” into classroom instruction: Benefits and strategies. Intervention in School and Clinic, 48(4), 246-253.
Blood, Erika, and Daniel Gulchak. "Embedding “Clickers” into classroom instruction: Benefits and strategies." Intervention in School and Clinic 48.4 (2013): 246-253.
Copy Download .nbib Format: MLA
Investigation of fasciculation and elongation protein ζ-1 (FEZ1) in peripheral blood reveals differences in gene expression in patients with schizophrenia.

Balkan journal of medical genetics : BJMG

Vachev TI, Stoyanova VK, Ivanov HY, Minkov IN, Popov NT.
PMID: 26929903
Balkan J Med Genet. 2015 Dec 30;18(1):31-8. doi: 10.1515/bjmg-2015-0003. eCollection 2015 Jun.

Schizophrenia (SZ) is a chronic neuropsychiatric disorder characterized by affective, neuromorphological and cognitive impairment, deteriorated social functioning and psychosis with underlying molecular abnormalities, including gene expression changes. Observations have suggested that fasciculation and elongation protein ζ-1 (FEZ1) may be...

Cite
Vachev TI, Stoyanova VK, Ivanov HY, et al. Investigation of fasciculation and elongation protein ζ-1 (FEZ1) in peripheral blood reveals differences in gene expression in patients with schizophrenia. Balkan J Med Genet. 2015;18(1):31-8doi: 10.1515/bjmg-2015-0003.
Vachev, T. I., Stoyanova, V. K., Ivanov, H. Y., Minkov, I. N., & Popov, N. T. (2015). Investigation of fasciculation and elongation protein ζ-1 (FEZ1) in peripheral blood reveals differences in gene expression in patients with schizophrenia. Balkan journal of medical genetics : BJMG, 18(1), 31-8. https://doi.org/10.1515/bjmg-2015-0003
Vachev, T I, et al. "Investigation of fasciculation and elongation protein ζ-1 (FEZ1) in peripheral blood reveals differences in gene expression in patients with schizophrenia." Balkan journal of medical genetics : BJMG vol. 18,1 (2015): 31-8. doi: https://doi.org/10.1515/bjmg-2015-0003
Vachev TI, Stoyanova VK, Ivanov HY, Minkov IN, Popov NT. Investigation of fasciculation and elongation protein ζ-1 (FEZ1) in peripheral blood reveals differences in gene expression in patients with schizophrenia. Balkan J Med Genet. 2015 Dec 30;18(1):31-8. doi: 10.1515/bjmg-2015-0003. eCollection 2015 Jun. PMID: 26929903; PMCID: PMC4768823.
Copy Download .nbib Format: NLM
DNA methylation signature in peripheral blood reveals distinct characteristics of human X chromosome numerical aberrations.

Clinical epigenetics

Sharma A, Jamil MA, Nuesgen N, Schreiner F, Priebe L, Hoffmann P, Herns S, Nöthen MM, Fröhlich H, Oldenburg J, Woelfle J, El-Maarri O.
PMID: 26221191
Clin Epigenetics. 2015 Jul 28;7:76. doi: 10.1186/s13148-015-0112-2. eCollection 2015.

BACKGROUND: Abnormal sex chromosome numbers in humans are observed in Turner (45,X) and Klinefelter (47,XXY) syndromes. Both syndromes are associated with several clinical phenotypes, whose molecular mechanisms are obscure, and show a range of inter-individual penetrance. In order to...

Cite
Sharma A, Jamil MA, Nuesgen N, et al. DNA methylation signature in peripheral blood reveals distinct characteristics of human X chromosome numerical aberrations. Clin Epigenetics. 2015;7:76doi: 10.1186/s13148-015-0112-2.
Sharma, A., Jamil, M. A., Nuesgen, N., Schreiner, F., Priebe, L., Hoffmann, P., Herns, S., Nöthen, M. M., Fröhlich, H., Oldenburg, J., Woelfle, J., & El-Maarri, O. (2015). DNA methylation signature in peripheral blood reveals distinct characteristics of human X chromosome numerical aberrations. Clinical epigenetics, 776. https://doi.org/10.1186/s13148-015-0112-2
Sharma, Amit, et al. "DNA methylation signature in peripheral blood reveals distinct characteristics of human X chromosome numerical aberrations." Clinical epigenetics vol. 7 (2015): 76. doi: https://doi.org/10.1186/s13148-015-0112-2
Sharma A, Jamil MA, Nuesgen N, Schreiner F, Priebe L, Hoffmann P, Herns S, Nöthen MM, Fröhlich H, Oldenburg J, Woelfle J, El-Maarri O. DNA methylation signature in peripheral blood reveals distinct characteristics of human X chromosome numerical aberrations. Clin Epigenetics. 2015 Jul 28;7:76. doi: 10.1186/s13148-015-0112-2. eCollection 2015. PMID: 26221191; PMCID: PMC4517491.
Copy Download .nbib Format: NLM
Increasing Salt Rejection of Polybenzimidazole Nanofiltration Membranes via the Addition of Immobilized and Aligned Aquaporins.

Processes (Basel, Switzerland)

Wagh P, Zhang X, Blood R, Kekenes-Huskey PM, Rajapaksha P, Wei Y, Escobar IC.
PMID: 31179235
Processes (Basel). 2019 Feb;7(2). doi: 10.3390/pr7020076. Epub 2019 Feb 03.

Aquaporins are water channel proteins in cell membrane, highly specific for water molecules while restricting the passage of contaminants and small molecules, such as urea and boric acid. Cysteine functional groups were installed on aquaporin Z for covalent attachment...

Cite
Wagh P, Zhang X, Blood R, et al. Increasing Salt Rejection of Polybenzimidazole Nanofiltration Membranes via the Addition of Immobilized and Aligned Aquaporins. Processes (Basel). 2019;7(2)doi: 10.3390/pr7020076.
Wagh, P., Zhang, X., Blood, R., Kekenes-Huskey, P. M., Rajapaksha, P., Wei, Y., & Escobar, I. C. (2019). Increasing Salt Rejection of Polybenzimidazole Nanofiltration Membranes via the Addition of Immobilized and Aligned Aquaporins. Processes (Basel, Switzerland), 7(2), . https://doi.org/10.3390/pr7020076
Wagh, Priyesh, et al. "Increasing Salt Rejection of Polybenzimidazole Nanofiltration Membranes via the Addition of Immobilized and Aligned Aquaporins." Processes (Basel, Switzerland) vol. 7,2 (2019). doi: https://doi.org/10.3390/pr7020076
Wagh P, Zhang X, Blood R, Kekenes-Huskey PM, Rajapaksha P, Wei Y, Escobar IC. Increasing Salt Rejection of Polybenzimidazole Nanofiltration Membranes via the Addition of Immobilized and Aligned Aquaporins. Processes (Basel). 2019 Feb;7(2). doi: 10.3390/pr7020076. Epub 2019 Feb 03. PMID: 31179235; PMCID: PMC6550480.
Copy Download .nbib Format: NLM
Brain-derived neurotrophic factor in hematological malignancies: From detrimental to potentially beneficial.

Blood reviews

Azoulay D, Horowitz NA.
PMID: 34344590
Blood Rev. 2021 Jul 28;100871. doi: 10.1016/j.blre.2021.100871. Epub 2021 Jul 28.

Emerging studies have highlighted brain-derived neurotrophic factor (BDNF), a neuronal growth factor abundant in the peripheral blood, and its tyrosine kinase receptor TRKB, as onco-genes and proteins that support the survival of malignant hematological cells. In contrast, other researchers...

Cite
Azoulay D, Horowitz NA. Brain-derived neurotrophic factor in hematological malignancies: From detrimental to potentially beneficial. Blood Rev. 2021;100871doi: 10.1016/j.blre.2021.100871.
Azoulay, D., & Horowitz, N. A. (2021). Brain-derived neurotrophic factor in hematological malignancies: From detrimental to potentially beneficial. Blood reviews, 100871. https://doi.org/10.1016/j.blre.2021.100871
Azoulay, David, and Horowitz, Netanel A. "Brain-derived neurotrophic factor in hematological malignancies: From detrimental to potentially beneficial." Blood reviews vol. (2021): 100871. doi: https://doi.org/10.1016/j.blre.2021.100871
Azoulay D, Horowitz NA. Brain-derived neurotrophic factor in hematological malignancies: From detrimental to potentially beneficial. Blood Rev. 2021 Jul 28;100871. doi: 10.1016/j.blre.2021.100871. Epub 2021 Jul 28. PMID: 34344590.
Copy Download .nbib Format: NLM
Antibiotics to modify sickle cell disease vaso-occlusive crisis?.

Blood reviews

Stewart C, Jang T, Mo G, Mohamed N, Poplawska M, Egini O, Dutta D, Lim SH.
PMID: 34304939
Blood Rev. 2021 Nov;50:100867. doi: 10.1016/j.blre.2021.100867. Epub 2021 Jul 17.

Despite the availability of hydroxyurea, the clinical use of the medication among patients with sickle cell disease (SCD) remains low in the United States. Given the high healthcare utilization cost, SCD requires new therapeutic approaches. Recent studies demonstrated bacterial...

Cite
Stewart C, Jang T, Mo G, et al. Antibiotics to modify sickle cell disease vaso-occlusive crisis?. Blood Rev. 2021;50:100867doi: 10.1016/j.blre.2021.100867.
Stewart, C., Jang, T., Mo, G., Mohamed, N., Poplawska, M., Egini, O., Dutta, D., & Lim, S. H. (2021). Antibiotics to modify sickle cell disease vaso-occlusive crisis?. Blood reviews, 50100867. https://doi.org/10.1016/j.blre.2021.100867
Stewart, Connor, et al. "Antibiotics to modify sickle cell disease vaso-occlusive crisis?." Blood reviews vol. 50 (2021): 100867. doi: https://doi.org/10.1016/j.blre.2021.100867
Stewart C, Jang T, Mo G, Mohamed N, Poplawska M, Egini O, Dutta D, Lim SH. Antibiotics to modify sickle cell disease vaso-occlusive crisis?. Blood Rev. 2021 Nov;50:100867. doi: 10.1016/j.blre.2021.100867. Epub 2021 Jul 17. PMID: 34304939.
Copy Download .nbib Format: NLM
A new frontier in Fanconi anemia: From DNA repair to ribosome biogenesis.

Blood reviews

Gueiderikh A, Maczkowiak-Chartois F, Rosselli F.
PMID: 34750031
Blood Rev. 2021 Oct 31;100904. doi: 10.1016/j.blre.2021.100904. Epub 2021 Oct 31.

Described by Guido Fanconi almost 100 years ago, Fanconi anemia (FA) is a rare genetic disease characterized by developmental abnormalities, bone marrow failure (BMF) and cancer predisposition. The proteins encoded by FA-mutated genes (FANC proteins) and assembled in the...

Cite
Gueiderikh A, Maczkowiak-Chartois F, Rosselli F. A new frontier in Fanconi anemia: From DNA repair to ribosome biogenesis. Blood Rev. 2021;100904doi: 10.1016/j.blre.2021.100904.
Gueiderikh, A., Maczkowiak-Chartois, F., & Rosselli, F. (2021). A new frontier in Fanconi anemia: From DNA repair to ribosome biogenesis. Blood reviews, 100904. https://doi.org/10.1016/j.blre.2021.100904
Gueiderikh, Anna, et al. "A new frontier in Fanconi anemia: From DNA repair to ribosome biogenesis." Blood reviews vol. (2021): 100904. doi: https://doi.org/10.1016/j.blre.2021.100904
Gueiderikh A, Maczkowiak-Chartois F, Rosselli F. A new frontier in Fanconi anemia: From DNA repair to ribosome biogenesis. Blood Rev. 2021 Oct 31;100904. doi: 10.1016/j.blre.2021.100904. Epub 2021 Oct 31. PMID: 34750031.
Copy Download .nbib Format: NLM
Perspective - The case for zero bleeds and drug bioequivalence in the treatment of congenital hemophilia A in 2021.

Blood reviews

Di Minno A, Spadarella G, Esposito S, Mathew P, Di Minno G, Mannucci PM.
PMID: 34024681
Blood Rev. 2021 Nov;50:100849. doi: 10.1016/j.blre.2021.100849. Epub 2021 May 07.

Not all patients with severe hemophilia A (HA) respond optimally to a given dose of a given product. Within-individual variance in cross-over studies makes each patient unique in the response to each standard half-life (SHL) factor VIII (FVIII) product...

Cite
Di Minno A, Spadarella G, Esposito S, et al. Perspective - The case for zero bleeds and drug bioequivalence in the treatment of congenital hemophilia A in 2021. Blood Rev. 2021;50:100849doi: 10.1016/j.blre.2021.100849.
Di Minno, A., Spadarella, G., Esposito, S., Mathew, P., Di Minno, G., & Mannucci, P. M. (2021). Perspective - The case for zero bleeds and drug bioequivalence in the treatment of congenital hemophilia A in 2021. Blood reviews, 50100849. https://doi.org/10.1016/j.blre.2021.100849
Di Minno, Alessandro, et al. "Perspective - The case for zero bleeds and drug bioequivalence in the treatment of congenital hemophilia A in 2021." Blood reviews vol. 50 (2021): 100849. doi: https://doi.org/10.1016/j.blre.2021.100849
Di Minno A, Spadarella G, Esposito S, Mathew P, Di Minno G, Mannucci PM. Perspective - The case for zero bleeds and drug bioequivalence in the treatment of congenital hemophilia A in 2021. Blood Rev. 2021 Nov;50:100849. doi: 10.1016/j.blre.2021.100849. Epub 2021 May 07. PMID: 34024681.
Copy Download .nbib Format: NLM
Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity.

Research square

Zhang W, Chua B, Selva K, Kedzierski L, Ashhurst T, Haycroft E, Shoffner S, Hensen L, Boyd D, James F, Mouhtouris E, Kwong J, Chua K, Drewett G, Copaescu A, Dobson J, Rowntree L, Habel J, Allen L, Koay HF, Neil J, Gartner M, Lee C, Andersson P, Seemann T, Sherry N, Amanat F, Krammer F, Londrigan S, Wakim L, King N, Godfrey D, Mackay L, Thomas P, Nicholson S, Arnold K, Chung A, Holmes N, Smibert O, Trubiano J, Gordon C, Nguyen T, Kedzierska K.
PMID: 34462740
Res Sq. 2021 Aug 26; doi: 10.21203/rs.3.rs-802084/v1.

Although the respiratory tract is the primary site of SARS-CoV-2 infection and the ensuing immunopathology, respiratory immune responses are understudied and urgently needed to understand mechanisms underlying COVID-19 disease pathogenesis. We collected paired longitudinal blood and respiratory tract samples...

Cite
Zhang W, Chua B, Selva K, et al. Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity. Res Sq. 2021;doi: 10.21203/rs.3.rs-802084/v1.
Zhang, W., Chua, B., Selva, K., Kedzierski, L., Ashhurst, T., Haycroft, E., Shoffner, S., Hensen, L., Boyd, D., James, F., Mouhtouris, E., Kwong, J., Chua, K., Drewett, G., Copaescu, A., Dobson, J., Rowntree, L., Habel, J., Allen, L., Koay, H. F., Neil, J., Gartner, M., Lee, C., Andersson, P., Seemann, T., Sherry, N., Amanat, F., Krammer, F., Londrigan, S., Wakim, L., King, N., Godfrey, D., Mackay, L., Thomas, P., Nicholson, S., Arnold, K., Chung, A., Holmes, N., Smibert, O., Trubiano, J., Gordon, C., Nguyen, T., & Kedzierska, K. (2021). Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity. Research square, . https://doi.org/10.21203/rs.3.rs-802084/v1
Zhang, Wuji, et al. "Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity." Research square vol. (2021). doi: https://doi.org/10.21203/rs.3.rs-802084/v1
Zhang W, Chua B, Selva K, Kedzierski L, Ashhurst T, Haycroft E, Shoffner S, Hensen L, Boyd D, James F, Mouhtouris E, Kwong J, Chua K, Drewett G, Copaescu A, Dobson J, Rowntree L, Habel J, Allen L, Koay HF, Neil J, Gartner M, Lee C, Andersson P, Seemann T, Sherry N, Amanat F, Krammer F, Londrigan S, Wakim L, King N, Godfrey D, Mackay L, Thomas P, Nicholson S, Arnold K, Chung A, Holmes N, Smibert O, Trubiano J, Gordon C, Nguyen T, Kedzierska K. Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity. Res Sq. 2021 Aug 26; doi: 10.21203/rs.3.rs-802084/v1. PMID: 34462740; PMCID: PMC8404907.
Copy Download .nbib Format: NLM
Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues.

Blood reviews

Kreitman RJ, Arons E.
PMID: 34535326
Blood Rev. 2022 Jan;51:100888. doi: 10.1016/j.blre.2021.100888. Epub 2021 Sep 04.

Hairy cell leukemia (HCL) is an indolent B-cell malignancy, usually driven by the BRAF V600E mutation. For 30 years, untreated and relapsed HCL was successfully treated with purine analogs, but minimal residual disease (MRD) remained in most patients, eventually...

Cite
Kreitman RJ, Arons E. Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues. Blood Rev. 2021;51:100888doi: 10.1016/j.blre.2021.100888.
Kreitman, R. J., & Arons, E. (2022). Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues. Blood reviews, 51100888. https://doi.org/10.1016/j.blre.2021.100888
Kreitman, Robert J, and Arons, Evgeny. "Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues." Blood reviews vol. 51 (2022): 100888. doi: https://doi.org/10.1016/j.blre.2021.100888
Kreitman RJ, Arons E. Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues. Blood Rev. 2022 Jan;51:100888. doi: 10.1016/j.blre.2021.100888. Epub 2021 Sep 04. PMID: 34535326; PMCID: PMC8418384.
Copy Download .nbib Format: NLM
Diagnosis of infectious diseases in immunocompromised hosts using metagenomic next generation sequencing-based diagnostics.

Blood reviews

Casto AM, Fredricks DN, Hill JA.
PMID: 34802773
Blood Rev. 2021 Nov 06;100906. doi: 10.1016/j.blre.2021.100906. Epub 2021 Nov 06.

The diagnosis of infectious diseases in immunocompromised hosts presents unique challenges for the clinician. Metagenomic next generation sequencing (mNGS) based diagnostics that identify microbial nucleic acids in clinical samples (mNGS for pathogen identification or mNGSpi) may be a useful...

Cite
Casto AM, Fredricks DN, Hill JA. Diagnosis of infectious diseases in immunocompromised hosts using metagenomic next generation sequencing-based diagnostics. Blood Rev. 2021;100906doi: 10.1016/j.blre.2021.100906.
Casto, A. M., Fredricks, D. N., & Hill, J. A. (2021). Diagnosis of infectious diseases in immunocompromised hosts using metagenomic next generation sequencing-based diagnostics. Blood reviews, 100906. https://doi.org/10.1016/j.blre.2021.100906
Casto, Amanda M, et al. "Diagnosis of infectious diseases in immunocompromised hosts using metagenomic next generation sequencing-based diagnostics." Blood reviews vol. (2021): 100906. doi: https://doi.org/10.1016/j.blre.2021.100906
Casto AM, Fredricks DN, Hill JA. Diagnosis of infectious diseases in immunocompromised hosts using metagenomic next generation sequencing-based diagnostics. Blood Rev. 2021 Nov 06;100906. doi: 10.1016/j.blre.2021.100906. Epub 2021 Nov 06. PMID: 34802773.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 101 entries